MONTAGNA, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 5.464
AS - Asia 16
NA - Nord America 2
AF - Africa 1
SA - Sud America 1
Totale 5.484
Nazione #
IT - Italia 5.463
CN - Cina 11
SG - Singapore 3
ID - Indonesia 2
US - Stati Uniti d'America 2
BR - Brasile 1
FI - Finlandia 1
KE - Kenya 1
Totale 5.484
Città #
Genova 3.030
Genoa 1.694
Vado Ligure 371
Rapallo 358
Bordighera 10
Beijing 5
Singapore 3
Ashburn 2
Belo Horizonte 1
Jakarta 1
Lappeenranta 1
Mombasa 1
Totale 5.477
Nome #
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 196
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 186
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 178
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 168
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 168
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 167
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. 162
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 154
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. 148
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 148
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 148
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 145
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis 143
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts 138
Anti-TNF and sex hormones 133
Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients. 133
A method for counting monosodium urate crystals in synovial fluid 128
Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients. 127
Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis. 126
Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis. 124
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 123
NF-KB involvement for CTLA4-IG intracellular signaling in human macrophages 120
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 119
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 119
17beta-Estradiol and testosterone influence the mRNA expression and the time course of inflammatory cytokines in activated human monocytic cell line (THP-1). 119
Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis 118
Synovial fluid estrogens in rheumatoid arthritis. 116
[Effects of estrogen peripheral metabolism in rheumatoid arthritis]. 111
Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients. 107
Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. 105
Use of glucocorticoids and risk of infections. 98
Estrogens modulate the effects of leflunomide on cytokine production by cultures of human monocytic/macrophage cells. 98
Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment. 84
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. 81
Sex hormone modulation of cell growth and apoptosis of human monocytic/macrophage cell line 76
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review 74
Sponges associated with stylasterid thanatocoenosis (Cnidaria, Hydrozoa) from the deep Ross Sea (Southern Ocean) 73
Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease 71
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients 71
Sex hormones and leflunomide treatment of human macrophage cultures: effects on apoptosis. 69
New roles for estrogens in rheumatoid arthritis. 67
Fibrosis in sclerodermia: endothelin increases fibronectin production and proliferation of skin Fibroblasts. 65
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease 60
null 58
Identification and quantification of selected inflammatory genes modulated by leflunomide and prednisone treatment in early rheumatoid arthritis patients. 57
Nailfold videocapillaroscopy patterns and specific autoantibodies in sclerodermia 55
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy 54
Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 51
AB0092 CTLA4-Ig PROMOTES THE M1-M2 SHIFT IN CULTURED MACROPHAGES OF RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE: IN VITRO STUDY 47
AB0080 IMBALANCE OF MONOCYTE/MACROPHAGE POLARIZATION IN PERIPHERAL BLOOD AND SYNOVIAL FLUID OF RHEUMATOID ARTHRITIS PATIENTS 45
AB0057 IN VITRO EFFECT OF CTLA4-IGG ON M1-M2 SHIFT OF MACROPHAGES FROM RHEUMATOID ARTHRITIS PATIENTS 39
SAT0301 CIRCULATING FIBROCYTES FROM SYSTEMIC SCLEROSIS PATIENTS AS POSSIBLE TARGET OF CTLA4-IG TREATMENT: AN IN VITRO STUDY 34
AB0682 CIRCULATING FIBROCYTES IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS PATIENTS: CORRELATION WITH DERMAL THICKNESS 7
AB0183 Isolation and characterization of circulating fibrocytes from systemic sclerosis patients: an vitro investigation 7
AB0182 In vitro characterization of dermal fibroblasts from systemic sclerosis patients 7
POS0330 NINTEDANIB (TYROSINE KINASE INHIBITOR) DOWNREGULATES THE TRANSITION OF CULTURED SYSTEMIC SCLEROSIS FIBROCYTES INTO MYOFIBROBLASTS AND THEIR PRO-FIBROTIC ACTIVITY 6
AB0185 Endothelin-1 stimulates the profibrotic alternative activated phenotype in cultured human macrophages isolated from systemic sclerosis patients 5
FRI0418 In vitro effects of ctla4-ig treatment on cultured fibrocytes from systemic sclerosis patients 4
FRI0423 Effects of selexipag in cultured scleroderma skin fibroblasts 4
FRI0417 Cd86 expression on cultured skin fibroblasts from systemic sclerosis patients: in vitro effects of ctla4-ig 3
THU0348 IDENTIFICATION OF CIRCULATING CELLS WITH AN HYBRID M1/M2 MACROPHAGE PHENOTYPE IN SYSTEMIC SCLEROSIS PATIENTS AND CORRELATIONS WITH SELECTED CLINICAL ASPECTS 3
THU0053 APREMILAST INHIBITS THE TGFî'1 MEDIATED TRANSITION OF CULTURED HUMAN SKIN FIBROBLASTS INTO PROFIBROTIC MYOFIBROBLASTS: IN VITRO STUDY 2
THU0347 TESTING THE IN VITRO EFFECTS OF NINTEDANIB ON CIRCULATING FIBROCYTES AND RESIDENT SKIN FIBROBLASTS FROM THE SAME SYSTEMIC SCLEROSIS PATIENTS: PRELIMINARY RESULTS 2
FRI0033 TNFalpha Production In Cultured Human Macrophages after CTLA4-IG (abatacept) In Vitro Treatment 2
OP0212 Endothelin-1 induces a profibrotic phenotype in cultured human microvascular endothelial and circulating monocyte/macrophage cells 1
THU0525 Counting Synovial Fluid Monosodium Urate Crystals May Be Useful in The Management of Patients with Gout 1
FRI0404 Characterisation of a monocytes/macrophages cell subset co-expressing both m1 and m2 phenotype markers in systemic sclerosis patients 1
THU0451 A method for counting calcium pyrophosphate crystals in the synovial fluid 1
Totale 5.660
Categoria #
all - tutte 18.558
article - articoli 18.558
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 23 31 27 6 26 24 32 32 33
2021/2022595 41 43 61 54 10 23 66 123 25 57 28 64
2022/2023436 43 34 11 36 60 68 3 29 57 2 88 5
2023/2024337 5 40 3 43 19 68 23 38 13 5 23 57
2024/20251.004 34 67 37 76 102 112 92 183 30 50 107 114
2025/2026726 245 137 149 195 0 0 0 0 0 0 0 0
Totale 5.660